IL2 and neoplasm: When the cell-fusion cytokine complexes were injected to tumor region, the GM-CSF part of fusion cytokine may interact with DCs in vivo which is consistent with the stronger interaction between DCs and tumor cells mediated by IL2-GMCSF in vitro.